Valmark Advisers Inc. Takes Position in Charles River Laboratories International, Inc. (NYSE:CRL) : vimarsana.com

Valmark Advisers Inc. bought a new stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 3,000 shares of the medical research company’s stock, valued at approximately $709,000. Other hedge funds […]

Related Keywords

Canada , United States , Asia Pacific , Robertw Baird , Dekabank Deutsche Girozentrale , Shannonm Parisotto , Investment Management , Manufacturing Solutions , Valmark Advisers Inc , Securities Exchange Commission , Charles River Laboratories International Stock , Regency Capital Management Inc , National Trust Bank , Quarter For Charles River Laboratories International , Exchange Commission , Research Models , Charles River Laboratories International , Charles River Laboratories International Inc , Valmark Advisers , Free Report , Capital Management , Bank Deutsche Girozentrale , Trust Bank , River Laboratories International , Get Free Report , Safety Assessment , Visit Holdingschannel , Charles River Laboratories International Daily , Nyse Crl , Crl , Medical , 15986410 , Sec Filings , 13f , Hedge Fund Holdings , Institutional Investor Holdings ,